Ertugliflozinum, Metformini hydrochloridum

Medicinal product name Segluromet
Pharmaceutical form Film-coated tablet
Strength 7.5 mg/1000 mg 
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresVēstule veselības aprūpes speciālistam Vēstule veselības aprūpes speciālistam
ATC code A10BD23 Drugs used in diabetes

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N56
(7,5 mg/1000 mg)
PA/Al/PVC/Al blister 52.68  EU/1/18/1265/025  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/18/1265/025
Date of authorisation Mar 23, 2018
Marketing authorisation holder, country Merck Sharp & Dohme B.V., Netherlands